Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study
β Scribed by Masako Hara; Tohru Abe; Sachiko Sugawara; Yutaka Mizushima; Keiko Hoshi; Shoichiro Irimajiri; Hiroshi Hashimoto; Shinichi Yoshino; Nobuo Matsui; Masashi Nobunaga; Shigeyuki Nakano
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 250 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1439-7595
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Objective. To evaluate the efficacy of an antLCD5 ricin-linked immunoconjugate (CD5-IC) in patients with rheumatoid arthritis (RA). Methods. A total of 104 evaluable patients were enrolled in a multicenter, double-blind, multiple-dose, placebo-controlled study of CDS-IC. Results. Treatment with CD
## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex